Starpharma Holdings Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	12.05	4.91	8.29	4.21	4.9
Other Revenue	0.62	0.94	1.47	0.14	0.26
Revenue	12.67	5.85	9.76	4.34	5.16
Revenue Growth	116.55%	-40.04%	124.64%	-15.87%	48.04%
Cost of Revenue	11.89	9.58	10.69	12.36	14.46
Gross Profit	0.77	-3.73	-0.93	-8.02	-9.29
Selling, General & Admin	8.24	6.26	7.24	7.62	6.86
Operating Expenses	8.24	6.26	7.24	7.62	6.86
Operating Income	-7.47	-9.99	-8.17	-15.64	-16.15
Pretax Income	-7.47	-9.99	-8.17	-15.64	-16.15
Earnings From Continuing Operations	-7.47	-9.99	-8.17	-15.64	-16.15
Net Income	-7.47	-9.99	-8.17	-15.64	-16.15
Net Income to Common	-7.47	-9.99	-8.17	-15.64	-16.15
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	420	417	411	409	407
Shares Outstanding (Diluted)	420	417	411	409	407
Shares Change	0.61%	1.40%	0.59%	0.53%	2.53%
EPS (Basic)	-0.02	-0.02	-0.02	-0.04	-0.04
EPS (Diluted)	-0.02	-0.02	-0.02	-0.04	-0.04
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-3.5	-6.8	-7.07	-14.93	-14
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.04	-0.03
Gross Margin	6.11%	-63.74%	-9.52%	-184.57%	-180.05%
Operating Margin	-58.93%	-170.77%	-83.69%	-360.07%	-312.94%
Profit Margin	-58.93%	-170.77%	-83.69%	-360.07%	-312.94%
Free Cash Flow Margin	-27.61%	-116.26%	-72.43%	-343.82%	-271.19%
EBITDA	-7.18	-9.72	-7.85	-15.25	-15.8
EBITDA Margin	-56.65%	-166.21%	-80.45%	-	-
D&A For EBITDA	0.29	0.27	0.32	0.39	0.36
EBIT	-7.47	-9.99	-8.17	-15.64	-16.15
EBIT Margin	-58.93%	-170.77%	-83.69%	-	-